Desing of cancer vaccines based on MUC1-Like Glycopeptides Containing Non-Natural Amino Acids
- Ó. Suárez 1
- A. Avenoza, 1
- J.M. Peregrina 1
- M. Zurbano 1
- F. Corzana 1
- J. H. Busto 1
- F. García-Martín 1
-
1
Universidad de La Rioja
info
Argitaletxea: Real Sociedad Española de Química
ISBN: 978-84-09-42159-6
Argitalpen urtea: 2022
Orrialdeak: 1135
Biltzarra: XXXVIII Reunión Bienal de la Real Sociedad Española de Química (RSEQ). Granada 27-30 de junio de 2022
Mota: Biltzarraren Kartela
beta Ver similares en nube de resultadosLaburpena
The Tn antigen (GalNAc-α-1-O-Thr) is a well-known tumor-associated carbohydrate determinant. The use of glycopeptides with this structure (e.g., mucin 1, MUC1) has become a promising field of research due to their potential use as cancer vaccines.[1] However, current vaccine candidates generally have weak in vivo immune responses due to their low stability and immunogenicity.[2]To address these drawbacks, we will modify several residues in the peptide sequence of MUC1 by unnatural amino acids, such as β-amino acids,[3] or surrogates of arginine residue.In this study, the synthetic routes and challenges encountered in obtaining the various homologues will be described. The affinity of a library of glycopeptides containing β-amino acids for the anti-MUC1 SM3 antibody will be presented and preliminary results will be discussed along with future prospects.
Erreferentzia bibliografikoak
- [1] I. A. Bermejo, C. D. Navo, et al. Chem. Sci. 2020, 11, 3996–4006.
- [2] I. Compañón, A. Guerreiro et al. J. Am. Chem. Soc. 2019, 141, 4063–4072.
- [3] R. Gibadullin, C. J. Randall, J. Sidney, A. Sette, S. H. Gellman. J. Am. Chem. Soc. 2021, 143, 6470–6481.